TLDR:
– Capitainer, a Swedish medtech company, has secured a SEK 30 million investment from We Venture Capital, the venture capital arm of the Werfen Group.
– The investment will help Capitainer become a leading provider of self-sampling solutions.
Swedish medtech company Capitainer has received a SEK 30 million investment from We Venture Capital, the venture capital arm of the Werfen Group. The investment is a strategic milestone for Capitainer as it aims to become the leading provider of self-sampling solutions. We Venture Capital specializes in empowering innovative companies in the diagnostic technology sector, aligning with their goal of transforming patient-oriented diagnostic solutions. The funding will be used to support Capitainer’s expansion efforts, including increasing production capacity, improving sales and marketing strategies, and launching new products. The investment will be administered in two phases, with the initial SEK 15 million being received before the end of this year and the remaining SEK 15 million a year later, contingent upon Capitainer achieving specific milestones. Alongside We Venture Capital, Sciety, a leading investment company, has also participated in this funding round, demonstrating their confidence in Capitainer’s vision and potential. Through its role as a facilitator and connector, Sciety has been instrumental in bringing Capitainer and We Venture Capital together and assisting with the negotiation of terms. This investment not only provides financial support for Capitainer’s growth plans but also marks the beginning of a potential long-term strategic collaboration.
